Mahdi Mahmoudi researcher
Mahmoudi, Mahdi
VIAF ID: 119151776836618012994 (Personal)
Permalink: http://viaf.org/viaf/119151776836618012994
Preferred Forms
- 100 0 _ ‡a Mahdi Mahmoudi ‡c researcher
-
- 100 1 _ ‡a Mahmoudi, Mahdi
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis | |
Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. | |
Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population. | |
Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis | |
Association of STAT4 rs7574865 with susceptibility to systemic lupus erythematosus in Iranian population. | |
Association study between killer immunoglobulin-like receptor polymorphisms and ankylosing spondylitis disease: An updated meta-analysis | |
c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts | |
Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. | |
A comprehensive overview on the genetics of Behçet's disease | |
Curcumin reduces the expression of interleukin 1β and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease | |
Cytokine gene polymorphisms in common variable immunodeficiency. | |
Dendritic Cells Currently under the Spotlight; Classification and Subset Based upon New Markers | |
Dysregulation of ribosome-related genes in ankylosing spondylitis: a systems biology approach and experimental method | |
Effect of all-transretinoic acid on Th17 and T regulatory cell subsets in patients with ankylosing spondylitis. | |
Epigenetic alterations underlying autoimmune diseases | |
Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous | |
Epigenetics in osteoarthritis: Novel spotlight | |
ERAP1 polymorphisms interactions and their association with Behçet's disease susceptibly: Application of Model-Based Multifactor Dimension Reduction Algorithm (MB-MDR) | |
Evaluating the reliability of Persian version of ankylosing spondylitis quality of life (ASQoL) questionnaire and related clinical and demographic parameters in patients with ankylosing spondylitis. | |
Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis | |
Genetic susceptibility to Graves’ ophthalmopathy: The role of polymorphisms in anti-inflammatory cytokine genes | |
HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis. | |
HLA-DRB1,-DQA1 and -DQB1 allele and haplotype frequencies in female patients with early onset breast cancer. | |
Identification of GJB2 Variants in 75 Unrelated Iranian Autosomal Recessive Non-syndromic Hearing Loss Patients | |
Identification of RELN variant p.(Ser2486Gly) in an Iranian family with ankylosing spondylitis; the first association of RELN and AS | |
Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis | |
Increased inflammatory responsiveness of peripheral blood mononuclear cells (PBMCs) to in vitro NOD2 ligand stimulation in patients with ankylosing spondylitis | |
The interleukin-1 family gene polymorphisms and Graves’ disease | |
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial | |
Liver alpha-amylase gene expression as an early obesity biomarker. | |
Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus. | |
microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients | |
microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients | |
New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis. | |
New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. | |
Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis | |
P2 receptors mRNA expression profiles in macrophages from ankylosing spondylitis patients and healthy individuals | |
PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. | |
The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis | |
The safety and efficacy of Guluronic acid (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial | |
Study of Programmed Cell Death 1 (PDCD1) Gene Polymorphims in Iranian Patients with Ankylosing Spondylitis | |
T-Helper 1, T-Helper 2, and T-Regulatory Cytokines Gene Polymorphisms in Irritable Bowel Syndrome | |
TNF-alpha single nucleotide polymorphisms in atopic dermatitis. | |
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer |